Showing results (1641-1650 of 1,849) with videos related to

Sort By:
Pageof 185
Chemistry & Biology|May 27, 2014
Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assaysFabio Stossi, Michael J Bolt, Felicity J Ashcroft, et al.
Eclinicalmedicine|August 2, 2023
Repeated antibiotic exposure and risk of hospitalisation and death following COVID-19 infection (OpenSAFELY): a matched case-control studyYa-Ting Yang, David Wong, Darren M Ashcroft, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 24, 2019
Assessing the severity of Type 2 diabetes using clinical data-based measures: a systematic reviewS S Zghebi, M Panagioti, M K Rutter, et al.
Acta Dermato-Venereologica|September 6, 2022
Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort StudyIreny Y K Iskandar, Teng-Chou Chen, Li-Chia Chen, et al.
Nature Cell Biology|March 21, 2007
R-type Ca(2+)-channel-evoked CICR regulates glucose-induced somatostatin secretionQuan Zhang, Martin Bengtsson, Chris Partridge, et al.
Frontiers in Oncology|October 20, 2018
VHL-Mediated Regulation of CHCHD4 and Mitochondrial FunctionThomas Briston, Jenna M Stephen, Luke W Thomas, et al.
Chemical Communications (Cambridge, England)|May 21, 2008
TiO2 nanoparticles as a soft X-ray molecular probeJared M Ashcroft, Weiwei Gu, Tierui Zhang, et al.
Plos One|March 28, 2025
Correction: Evaluation of the impact of COVID-19 pandemic on hospital admission related to common infections: Risk prediction models to tackle antimicrobial resistance in primary careAli Fahmi, Victoria Palin, Xiaomin Zhong, et al.
Bone Marrow Transplantation|June 29, 2022
Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory studyJohn A Snowden, Sam H Ahmedzai, Angela Cox, et al.
The British Journal of Dermatology|August 3, 2018
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Z Z N Yiu, D M Ashcroft, I Evans, et al.
Pageof 185